Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections

被引:0
作者
Stijn P. Andeweg
Brechje de Gier
Dirk Eggink
Caroline van den Ende
Noortje van Maarseveen
Lubna Ali
Boris Vlaemynck
Raf Schepers
Susan J. M. Hahné
Chantal B. E. M. Reusken
Hester E. de Melker
Susan van den Hof
Mirjam J. Knol
机构
[1] Center for Infectious Disease Control,Department of Medical Microbiology
[2] National Institute for Public Health and the Environment (RIVM),undefined
[3] Saltro Diagnostic Center for Primary Care,undefined
[4] University Medical Center Utrecht,undefined
[5] SYNLAB,undefined
来源
Nature Communications | / 13卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Given the emergence of the SARS-CoV-2 Omicron BA.1 and BA.2 variants and the roll-out of booster COVID-19 vaccination, evidence is needed on protection conferred by primary vaccination, booster vaccination and previous SARS-CoV-2 infection by variant. We employed a test-negative design on S-gene target failure data from community PCR testing in the Netherlands from 22 November 2021 to 31 March 2022 (n = 671,763). Previous infection, primary vaccination or both protected well against Delta infection. Protection against Omicron BA.1 infection was much lower compared to Delta. Protection was similar against Omicron BA.1 compared to BA.2 infection after previous infection, primary and booster vaccination. Higher protection was observed against all variants in individuals with both vaccination and previous infection compared with either one. Protection against all variants decreased over time since last vaccination or infection. We found that primary vaccination with current COVID-19 vaccines and previous SARS-CoV-2 infections offered low protection against Omicron BA.1 and BA.2 infection. Booster vaccination considerably increased protection against Omicron infection, but decreased rapidly after vaccination.
引用
收藏
相关论文
共 50 条
[41]   Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 [J].
Fiaschi, Lia ;
Dragoni, Filippo ;
Schiaroli, Elisabetta ;
Bergna, Annalisa ;
Rossetti, Barbara ;
Giammarino, Federica ;
Biba, Camilla ;
Gidari, Anna ;
Lai, Alessia ;
Nencioni, Cesira ;
Francisci, Daniela ;
Zazzi, Maurizio ;
Vicenti, Ilaria .
VIRUSES-BASEL, 2022, 14 (07)
[42]   Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2 [J].
Hu, Bingjie ;
Chan, Jasper Fuk-Woo ;
Liu, Huan ;
Liu, Yuanchen ;
Chai, Yue ;
Shi, Jialu ;
Shuai, Huiping ;
Hou, Yuxin ;
Huang, Xiner ;
Yuen, Terrence Tsz-Tai ;
Yoon, Chaemin ;
Zhu, Tianrenzheng ;
Zhang, Jinjin ;
Li, Wenjun ;
Zhang, Anna Jinxia ;
Zhou, Jie ;
Yuan, Shuofeng ;
Zhang, Bao-Zhong ;
Yuen, Kwok-Yung ;
Chu, Hin .
EMERGING MICROBES & INFECTIONS, 2022, 11 (01) :2275-2287
[43]   Co-infection with SARS-CoV-2 omicron BA.1 and BA.2 subvariants in a non-vaccinated woman [J].
Vatteroni, Maria Linda ;
Capria, Anna-Lisa ;
Spezia, Pietro Giorgio ;
Frateschi, Susi ;
Pistello, Mauro .
LANCET MICROBE, 2022, 3 (07) :E478-E478
[44]   Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark [J].
Frederik Plesner Lyngse ;
Carsten Thure Kirkeby ;
Matthew Denwood ;
Lasse Engbo Christiansen ;
Kåre Mølbak ;
Camilla Holten Møller ;
Robert Leo Skov ;
Tyra Grove Krause ;
Morten Rasmussen ;
Raphael Niklaus Sieber ;
Thor Bech Johannesen ;
Troels Lillebaek ;
Jannik Fonager ;
Anders Fomsgaard ;
Frederik Trier Møller ;
Marc Stegger ;
Maria Overvad ;
Katja Spiess ;
Laust Hvas Mortensen .
Nature Communications, 13
[45]   SARS-CoV-2 Serology Did Not Predict Risk of Breakthrough Infection During the Omicron BA.1 and BA.2 Surge [J].
Bruxvoort, Katia J. ;
Shi, Jiaxiao ;
Song, Hubert ;
Narwaney, Komal ;
Glanz, Jason M. ;
Binswanger, Ingrid ;
Lam, Jessica A. ;
Chang, John M. ;
Portugal, Cecilia ;
Watanabe, Cheryl ;
Aragones, Michael ;
Palmer-Toy, Darryl E. .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2024, 148 (01) :7-11
[46]   Convalescent Plasma Therapy in Immunocompromised Patients Infected With the BA.1 or BA.2 Omicron SARS-CoV-2 [J].
Richier, Quentin ;
De Valence, Benjamin ;
Chopin, Dorothee ;
Gras, Emmanuelle ;
Levi, Laura I. ;
Aad, Yasmine Abi ;
Pacanowski, Jerome ;
Meynard, Jean-Luc ;
Placais, Leo ;
Fey, Dorothee ;
Couture, Priscille ;
Martin-Blondel, Guillaume ;
Pestre, Vincent ;
Woessner, Juliette ;
Ancellin, Sophie ;
Weyrich, Pierre ;
Carpentier, Benjamin ;
Idri, Salim ;
Tiberghien, Pierre ;
Surgers, Laure ;
Hueso, Thomas ;
Lacombe, Karine .
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2024, 18 (03)
[47]   Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2 [J].
Pastorio, Chiara ;
Zech, Fabian ;
Noettger, Sabrina ;
Jung, Christoph ;
Jacob, Timo ;
Sanderson, Theo ;
Sparrer, Konstantin M. J. ;
Kirchhoff, Frank .
CELL HOST & MICROBE, 2022, 30 (09) :1255-+
[48]   Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark [J].
Lyngse, Frederik Plesner ;
Kirkeby, Carsten Thure ;
Denwood, Matthew ;
Christiansen, Lasse Engbo ;
Molbak, Kare ;
Moller, Camilla Holten ;
Skov, Robert Leo ;
Krause, Tyra Grove ;
Rasmussen, Morten ;
Sieber, Raphael Niklaus ;
Johannesen, Thor Bech ;
Lillebaek, Troels ;
Fonager, Jannik ;
Fomsgaard, Anders ;
Moller, Frederik Trier ;
Stegger, Marc ;
Overvad, Maria ;
Spiess, Katja ;
Mortensen, Laust Hvas .
NATURE COMMUNICATIONS, 2022, 13 (01)
[49]   Clinical Efficacy of the Neutralizing Antibody Therapy Sotrovimab in Patients with SARS-CoV-2 Omicron BA.1 and BA.2 Subvariant Infections [J].
Miyashita, Naoyuki ;
Nakamori, Yasushi ;
Ogata, Makoto ;
Fukuda, Naoki ;
Yamura, Akihisa ;
Ishiura, Yoshihisa ;
Ito, Tomoki .
VIRUSES-BASEL, 2023, 15 (06)
[50]   Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study [J].
He, Xiaofeng ;
Zeng, Biao ;
Wang, Ye ;
Pang, Yulian ;
Zhang, Meng ;
Hu, Ting ;
Liang, Yuanhao ;
Kang, Min ;
Tang, Shixing .
FRONTIERS IN IMMUNOLOGY, 2023, 14